The current socioeconomic and regulatory landscape of immune effector cell therapies

The current socioeconomic and regulatory landscape of immune effector cell therapies

Immune cell effector therapies, including chimeric antigen receptor (CAR)-T cells, T-cell receptor (TCR) T cells, natural killer (NK) cells, and macrophage-based therapies, represent a transformative approach to cancer treatment, harnessing the immune system to target and eradicate malignant cells....

Full description

Saved in:
Bibliographic Details
Main Authors: Chiranjeevi Sainatham, Devvrat Yadav, Aravind Dilli Babu, Jayanth Reddy Tallapalli, Sai Gautham Kanagala, Evgenii Filippov, Franco Murillo Chavez, Nausheen Ahmed, Forat Lutfi
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Medicine
Subjects:
CAR T-cell therapy
immune effector cell therapy
regulatory environment for cellular therapeutics
bispecific antibodies (BsAbs)
TILs (tumor infiltrating lymphocytes)
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1462307/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2024.1462307/full

Similar Items